GEM and cholangiocarcinoma: To further evaluate the antitumor efficacy of the various formulations, we established a xenograft model of human CCA according to the schematic shown in Fig. 7B. Notably, consistent with the in vitro findings, Gem-aPKCι-siRNA-L-treated tumors had the smallest sizes among those of all treatment groups (Fig. 7C).